Pharma / Biotech

FDA Approves Delstrigo and Pifeltro for HIV Treatment

The FDA approved Merck’s two doravirine-based HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate; and Pifeltro, a new non-nucleoside reverse transcriptase inhibitor.

Source link

Related posts

CURE ID Site Gains Traffic From Experimental Coronavirus Rx Reports


METFORMIN HYDROCHLORIDE Tablet [Denton Pharma, Inc. DBA Northwind Pharmaceuticals]


CHERRY COUGH DROPS (Menthol) Lozenge [Family Dollar]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy